APERAM S.A. NY SHS/1 O.N.APERAM S.A. NY SHS/1 O.N.APERAM S.A. NY SHS/1 O.N.

APERAM S.A. NY SHS/1 O.N.

No trades
See on Supercharts

Price target

30.990.00 0.00%
The 8 analysts offering 1 year price forecasts for 7AAN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to 7AAN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

7AAN EPS for the last quarter is 0.96 EUR despite the estimation of −0.04 EUR. In the next quarter EPS is expected to reach −0.04 EUR. Track more of APERAM S.A. NY SHS/1 O.N. financials and stay on top of what is up with the company.
In the next quarter APERAM S.A. NY SHS/1 O.N. revenue is expected to reach ‪1.55 B‬ EUR. Check out APERAM S.A. NY SHS/1 O.N. revenue and earnings and make informed decisions.
According to analysts, 7AAN price target is 30.99 EUR with a max estimate of 42.89 EUR and a min estimate of 25.03 EUR. Check if this forecast comes true in a year, meanwhile keep track of the current situation with 7AAN news and stock market news.
We've gathered opinions of 8 analysts rating 7AAN stock in the past 3 months. After counting all points of view, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.